Halyard Health (HYH) has been under a strong bear grip, hence the stock is down -0.22% when compared to the S&P 500 in the past 4 weeks. However, in the near-term, buying emerged at lower levels and the stock has outperformed the S&P 500 by 3.17% in the past 1 week. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 3.1% in the last 1 week, and is up 3.13% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The stock has recorded a 20-day Moving Average of 2.15% and the 50-Day Moving Average is 6.42%. Halyard Health, Inc. is up 22.83% in the last 3-month period. Year-to-Date the stock performance stands at 3.53%.
Halyard Health (NYSE:HYH): stock turned positive on Friday. Though the stock opened at $34.28, the bulls momentum made the stock top out at $34.94 level for the day. The stock recorded a low of $34.28 and closed the trading day at $34.59, in the green by 0.70%. The total traded volume for the day was 962,049. The stock had closed at $34.35 in the previous days trading.
Halyard Health, Inc. seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company has two business segments: Surgical and Infection Prevention (S&IP) and Medical Devices. The Companys S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections. S&IPs product portfolio includes sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves. Medical Devices segment provides a portfolio of product offerings, including post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems and enteral feeding tubes, focused on pain management and respiratory and digestive health.